Drug discovery software developer Optibrium has released of the newest version of its StarDrop software platform for small-molecule design, optimization and data analysis. The new release, StarDrop 7.0, further extends the software’s compound design strategies, provides enhanced workflows, and seamlessly connects with Optibrium’s Cerella platform, delivering unique AI capabilities to drug discovery scientists. More than 150 organizations worldwide use StarDrop in their research programmes and the new features have been developed in close collaboration with key customers to aid in identifying optimally balanced, successful and novel compounds faster.

A new feature of the software is Reaction-based Library Enumeration (RBE), which enables chemists to easily enumerate compound libraries and explore optimization strategies. RBE delivers a highly-flexible and user-friendly environment to generate new molecules by applying tractable, robust chemical reactions and linking directly with in-house and commercial building block libraries. Combined with StarDrop’s multi-parameter optimization capabilities, this enables medicinal chemists to target high-quality and synthetically accessible compounds.

StarDrop 7.0 seamlessly integrates with Cerella, Optibrium’s newly introduced AI software platform, providing intuitive workflows that leverage Cerella’s capabilities to accelerate discovery cycles and reduce costs while targeting high-quality compounds. Deploying advanced deep learning methods, Cerella has been demonstrated to extract additional value from compound data, highlighting relationships between structures, activities and other properties.